XYLOCAINE 2%-EPI 1:100,000

LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
$0.2655per ML

Strength

.01; 20 mg/mL; mg/mL

NDC

63323048327

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

INFILTRATION; PERINEURAL

Last Updated

2/1/2025

Approval Type

New Drug (NDA)

FDA Application

NDA006488

On Market Since

8/12/2010

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Agonists
Amide Local Anesthetic
Amides
Antiarrhythmic
Catecholamine
Catecholamines
Local Anesthesia
alpha-Adrenergic Agonist
beta-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+18.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.